Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
20 results
D2.65 - Clinical relevance of sensitizations to pneumoallergens detected in southern Spain
D2.66 - Deciphering The Molecular Profiles Between Asthma and Urticaria Using Transcriptomic Profiling
D2.67 - Relation betwween IL-6 and asthma in children and adolescent
D2.69 - Symptom Variability in Hypereosinophilic Syndrome: Observations From a Large Cohort Study
D2.70 - The Impact of Comorbidity of respiratory and atopic diseases on Mental Health and Wellbeing: a Community Survey in the US and Eastern Europe
D2.71 - Comprehensive approach to severe bronchial asthma: a case study and the role of biologic therapy
D2.72 - Analysis of asthma prevalence and risk factors in infantile atopic dermatitis using data from the Korean national health insurance serice
D2.73 - Activation-induced marker (AIM) assay to study allergic skin reactions: a case study on p-phenylenediamine
D2.74 - Analytical Verification of House Dust Mite Allergen Assays on the IMMULITE 2000 XPi System*
D2.75 - Allergy to insects in children
D2.76 - When Eosinophilia Persists: Unmasking an Unexpected Diagnosis in a Dupilumab Treated Atopic Dermatitis Patient
D2.77 - A Novel Neural Network for Quantifying Wheal and Erythema in Skin Prick Testing
D2.78 - Hypersensitivity Reactions to Biologics in Patients with Th1- and Th17-Driven Immune-Mediated Diseases: A Series of Three Cases
D1.402 - Study of lymphocyte populations and subpopulations in patients with long-COVID with reactivation of herpesvirus type 6 infection
D1.397 - Eosinophilic Pneumonia Triggered by Toxocara canis in a Patient with Kartagener Syndrome: A Case Report Highlighting Diagnostic Challenges and Interdisciplinary Management
D1.398 - Retrospective study of the effect of bacterial immunotheraphy on patients with chronic respiratory diseases
D1.403 - Use of ketotifen as treatment for post viral infection cough in children
D1.404 - Use of inactivated polybacterial mucosal vaccine (IPMV) as part of the treatment for the reduction of recurrent acute respiratory infections
D1.405 - Immunological imprinting of IgG response to RV VP1 in children of the MAS and PAPS birth cohorts
D1.406 - The microbiota of the urogenital canal related to papillomavirus infection
Download the app
The congress at your fingertips
Available on
Download